CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis
Carla Greco, Daniele Santi, Giulia Brigante, Chiara Pacchioni, Manuela Simoni
Diabetes Metab J. 2022;46(6):901-911.   Published online April 12, 2022
DOI: https://doi.org/10.4093/dmj.2021.0314

Excel Download

Effect of the Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists on Autonomic Function in Subjects With Diabetes: a Systematic Review and Meta-analysis.
. 2021;   Crossref logo
Link1 Link2

Effect of the Glucagon-Like Peptide-1 Receptor Agonists on Autonomic Function in Subjects with Diabetes: A Systematic Review and Meta-Analysis
Diabetes & Metabolism Journal. 2022;46(6):901-911   Crossref logo
Link1 Link2 Link3

Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis
Diabetes & Metabolism. 2022;48(5):101366   Crossref logo
Link1 Link2

The effect of glucagon-like peptide 1 and glucagon-like peptide 1 receptor agonists on energy expenditure: A systematic review and meta-analysis
Diabetes Research and Clinical Practice. 2018;142:222-235   Crossref logo
Link1 Link2

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
BMJ. 2022;o109   Crossref logo
Link1 Link2

Glucagon-Like Peptide 1 Receptor Agonists Protect Against Stroke In Patients With Diabetes: A Systematic Review And Meta-Analysis
Atherosclerosis. 2019;287:e116   Crossref logo
Link1 Link2

Glucagon-like peptide 1 receptor agonists and protection against stroke: a systematic review and meta-analysis
Atherosclerosis. 2018;275:e62   Crossref logo
Link1 Link2

Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis
Journal of Diabetes and its Complications. 2022;36(9):108285   Crossref logo
Link1 Link2

Withdrawal: “Effect of glucagon‐like peptide‐1 receptor agonists in subjects with type 2 diabetes mellitus: A meta‐Analysis” Weiyun Qian, Fei Liu, Qichao Yang
International Journal of Clinical Practice. 2021;75(10):   Crossref logo
Link1 Link2 Link3

Effect of glucagon‐like peptide‐1 receptor agonists in subjects with type 2 diabetes mellitus: A meta‐analysis
Journal of Clinical Pharmacy and Therapeutics. 2021;46(6):1650-1658   Crossref logo
Link1 Link2 Link3